MARKET

SSKN

SSKN

Strata Skin Sciences Inc
NASDAQ
0.3780
-0.0669
-15.04%
Closed 16:00 03/28 EDT
OPEN
0.4400
PREV CLOSE
0.4449
HIGH
0.4401
LOW
0.3600
VOLUME
136.66K
TURNOVER
0
52 WEEK HIGH
1.150
52 WEEK LOW
0.2620
MARKET CAP
13.25M
P/E (TTM)
-1.2190
1D
5D
1M
3M
1Y
5Y
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q4 2023
Strata Skin Sciences reported earnings per share of -4 cents. The company reported revenue of $8.69 million. This was 13.20% worse than the analyst estimate for the company to report revenue of $10.01 million. The company also reported lower-than-expected revenue.
Investorplace · 1d ago
STRATA Skin Sciences Unveils Annual Financial Results
TipRanks · 1d ago
STRATA Skin Sciences Inc reports results for the quarter ended in December - Earnings Summary
STRATA Skin Sciences Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 11 cents per share. Revenue fell 41.4% to $6.21 million from a year ago. The average analyst rating on the shares is "strong buy"
Reuters · 1d ago
Strata Skin Sciences Q4 EPS $(0.04) Misses $(0.02) Estimate, Sales $8.69M Miss $10.01M Estimate
Strata Skin Sciences reported quarterly losses of $0.04 per share. The company reported quarterly sales of $8.69 million which missed the analyst consensus estimate of $10.01 million by 13.20%. The company also reported a 700 percent decrease in sales from last year.
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The company's Q4 earnings report came out today. Fresh2 Group stock rose upwards by 5.26% as well.
Benzinga · 1d ago
Recap: Strata Skin Sciences Q4 Earnings
Strata Skin Sciences reported its Q4 earnings on March 27. The company missed its earnings estimate by $0.04. The firm's revenue was down $1.91 million from the same period last year. Strata skin Sciences is expected to announce its earnings on April 27.
Benzinga · 1d ago
STRATA Skin Sciences GAAP EPS of -$0.11 misses by $0.09, revenue of $8.7M misses by $1.31M
Seeking Alpha · 1d ago
*Strata Skin Sciences 4Q Rev $8.7M >SSKN
Dow Jones · 1d ago
More
About SSKN
STRATA Skin Sciences, Inc. is a medical technology company. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions such as psoriasis, vitiligo, and acne. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The Company's XTRAC excimer laser delivers a targeted therapeutic beam of ultraviolet B (UVB) light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. Pharos is its excimer laser device that emits concentrated ultraviolet (UV) light and is used as a tool in the treatment of dermatological skin disorders.

Webull offers STRATA Skin Sciences Inc stock information, including NASDAQ: SSKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SSKN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SSKN stock methods without spending real money on the virtual paper trading platform.